However, when we analyzed the specific immune response mediated by CD8+ T cells, previously determined with the HLA-peptide dextramers, we observed that the percentage of SARS-CoV-2-specific CD8+ T cells was lower in patients with PASC compared with those that did not develop PASC (Figure 4c). Here, CD8A is linked to long COVID-19.